OGN Organon & Co. Loading... : Bullish and Bearish Analyst Opinions
Loading chart...
Top Calls
Feed
18:33
May 15
May 15
SEC FOIA logs reveal ongoing investigations for listed companies, indicating regulatory scrutiny but no directional view expressed.
HIGH
00:09
Apr 28
Apr 28
M&A announcement: Sun Pharma to acquire Organon for $11.75B. Factual report, no directional view from speaker.
HIGH
00:07
Apr 27
Apr 27
Organon received a takeover bid, validating its depressed valuation; anticipate price appreciation toward the bid premium.
HIGH
20:23
Apr 10
Apr 10
Organon shares climbed ~28% after a report that Sun Pharmaceutical is set to make a $12B offer, following a prior 8% gain on related speculation. Sun called the report "speculative." The stock's extreme reaction to successive days of M&A speculation indicates the market assigns a high probability to a deal, with reports claiming detailed due diligence has been completed. WATCH due to high, event-driven volatility centered on a potential takeover, where the outcome is binary and dependent on a formal offer materializing. The deal fails to materialize, causing the speculative premium to collapse.
About OGN Analyst Coverage
Buzzberg tracks OGN (Organon & Co.) across 4 sources. 0 bullish vs 0 bearish calls from 4 analysts. Sentiment: evenly split. 4 total trade ideas tracked.